The theoretical bases of Hodgkin's disease (HD) have recently been revised in the light of
new findings obtained by means of immunohistochemistry and molecular analysis. These …

Paraffin blocks and clinical data from 521 patients with lymphocyte predominance Hodgkin
disease (LPHD) diagnosed between 1970 and 1994 were collected from 16 European and …

Since lymphocyte predominant Hodgkin's disease (LPHD) may comprise more than one
entity, diagnostic criteria, clinical features, and treatment strategies are still being …

The final Workshop of the meeting focused on cases of Hodgkin's disease (HD) in
combination with non-Hodgkin's lymphoma (NHL), either T, B, or anaplastic large cell (ALC) …

Summary Background While Hodgkin's disease (HD) and the non-Hodgkin's lymphomas
(NHLs) have long been regarded as distinct disease entities, recent observations suggest a …

Although Hodgkin's disease is relatively well defined, there are borderline cases in which
this disease overlaps with non-Hodgkin's lymphoma. Fortunately, there are only two such …

Summary Background Lymphocyte predominant Hodgkin's disease (LP-HD), particularly
that with a nodular pattern has been suggested to constitute a distinct disorder within the …

Workshop C included cases with a differential diagnosis of Hodgkin's disease and B cell
lymphoma. In general, the cases could be placed into one of the following four major …

There is wide consensus that lymphocyte predominance Hodgkin's disease (LPHD)
represents a distinct clinicopathological entity of B-cell origin. However, inconsistent results …

THE RETROSPECTIVE REPORT from the multicenter European Task Force on Lymphoma
(ETFL) project appearing in this edition of the Journal of Clinical Oncology1 compares the …